Updates are available Correction dated 2022-11-08
Click to view Correction: https://doi.org/10.1038/s41375-022-01721-y
-
Authors
Koschade, Sebastian E. https://orcid.org/0000-0001-5770-1279
Klann, Kevin
Shaid, Shabnam
Vick, Binje https://orcid.org/0000-0003-1956-2778
Stratmann, Jan A.
Thölken, Marlyn
Meyer, Laura M. https://orcid.org/0000-0001-9276-4320
Nguyen, The Duy
Campe, Julia
Moser, Laura M.
Hock, Susanna
Baker, Fatima
Meyer, Christian T.
Wempe, Frank
Serve, Hubert
Ullrich, Evelyn https://orcid.org/0000-0001-8530-1192
Jeremias, Irmela https://orcid.org/0000-0003-1773-7677
Münch, Christian https://orcid.org/0000-0003-3832-090X
Brandts, Christian H. https://orcid.org/0000-0003-1732-2535
- License Information
-
More Information
Article History
Received: 6 December 2021
Revised: 29 July 2022
Accepted: 2 August 2022
First Online: 23 August 2022
Change Date: 8 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-022-01721-y
Competing interests
: CTM is a co-founder and partial equity holders in Parthenon Therapeutics. The other authors declare no potential conflicts of interest.
